| FAPI-04 Lu-177 |
FAPI-04 LU-177 |
2374784-95-7 |
| Lutetium Lu 177 Satoreotide Tetraxetan |
LUTETIUM LU 177 SATOREOTIDE TETRAXETAN |
2211152-69-9 |
| (68Ga)Nota-prgd2 |
(68GA)NOTA-PRGD2 |
1345968-02-6 |
| D-Tyrosinamide, N-[4-[4,7-bis(carboxymethyl)octahydro-1H-1,4,7-triazonin-1-yl]-4-carboxy-1-oxobutyl]-4-chloro-L-phenylalanyl-D-cysteinyl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
NODAGA-JR11/JR-11-NODAGA |
1638746-88-9 |
| 1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[15-carboxy-6,6-dimethyl-13,13-dioxido-3,9,18-trioxo-18-[4-[2-[(1,4,5,6-tetrahydro-2-pyrimidinyl)amino]ethoxy]phenyl]-8-oxa-13-thia-4,10,14,17-tetraazaoctadec-1-yl]hexahydro- |
NODAGA-THERANOST |
1393933-89-5 |
| D-Tyrosinamide, 4-chloro-L-phenylalanyl-D-cysteinyl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
SATOREOTIDE |
1801415-23-5 |
| Cuprate(2-)-64Cu, [N-[2-[4,10-bis[(carboxy-κO)methyl]-7-(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl-κN1,κN4,κN7,κN10]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threonine cyclic (2→7)-disulfidato(4-)]-, hydrogen (1:2), (OC-6-12)- |
CU-64 DOTA-TATE |
1426155-87-4 |
| 1H-1,4,7-Triazonine-1,4,7-triacetic acid, 2-[(4-aminophenyl)methyl]hexahydro-, hydrochloride (1:4), (2S)- |
2-((4-AMINOPHENYL)METHYL)NOTA TETRAHYDROCHLORIDE |
1310812-52-2 |
| 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α10-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester, (α1S)- |
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID, Α10-(2-CARBOXYETHYL)-, 1,4,7,10-TETRAKIS( |
1023889-20-4 |
| FAPI-2 Ga-68 |
FAPI-2 Ga-68 |
2374784-94-6 |
| (S)-N-(2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)-6-(3-(piperazin-1-yl)propoxy)quinoline-4-carboxamide hydrochloride |
FAPI |
2579689-19-1 |
| Cyclo(RGDfK(Azido PEG4)) |
RGD叠氮环肽 |
2227549-75-7 |
| L-Phenylalanine, N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-N-methyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl- |
NHS-MMAF |
1404073-19-3 |
| INDEX NAME NOT YET ASSIGNED |
DBCO-PEG4-VAL-CIT-PAB-MMAF |
2244602-23-9 |
| L-Valinamide, N-[[[3-[[3-[[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]amino]-1-oxopropyl]amino]-4-(β-D-glucopyranuronosyloxy)phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl- |
MC-BETAGLUCURONIDE-MMAE-1 |
1703778-92-0 |
| INDEX NAME NOT YET ASSIGNED |
SUO-GLU-VAL-CIT-PAB-MMAE |
1895916-24-1 |
| MC-Alkyl-Hydrazine Modified MMAF |
MC-Alkyl-Hydrazine Modified MMAF |
1404071-64-2 |
| L-Cysteine, S-[[3-(mercaptomethyl)-5-[[[2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]amino]ethyl]thio]methyl]phenyl]methyl]-N-(1-oxohexyl)-L-cysteinyl-L-prolyl-L-prolyl-L-threonyl-L-glutaminyl-L-phenylalanyl-, cyclic (1→7)-thioether |
FAP2286 |
2581741-18-4 |
| 2,4-Quinolinedicarboxylic acid, 6-hydroxy- |
6-HYDROXYQUINOLINE-2,4-DICARBOXYLIC ACID |
5557-56-2 |
| Fmoc-Asn-Pro-Val-PABC-PNP |
FMOC-ASN-PRO-VAL-PABC-PNP |
2893871-64-0 |
QQ
微信
